Pfizer-BioNTech announced on Tuesday they have begun late-stage clinical trials of their coronavirus vaccine in children ages five to 11
Lower doses will be used for kids, 10 micrograms, compared to the 30 micrograms that those ages 12 and above receive
The company says it is hoping for data in the latter half of 2021, and is still in the early stages for trials in children between six months to four years old
On Monday, Moderna CEO Stéphane Bancel said he believes his company’s vaccine will be available for kids as young as five years old by early fall
Parents and doctors have been debating about whether or not to inoculate children because they make up just 0.1% of all COVID deaths
Categories